CSBR News and Press, Champions Oncology Inc. From 07/17/25

Himalaya Technologies Inc (HMLA) is expected to report for quarter end 2025-04-30 Bankinter SA ADR (BKNIY) is expected to report $0.29 for Q2 2025 Srivaru Holding (SVUHF) is expected to report for quarter end 2025-03-31 ABB Ltd. (ABBNY) is expected to report $1.29 for Q2 2025 Euro...

Champions Oncology Inc. (CSBR) is expected to report for quarter end 2025-04-30

2025-07-15 18:46:05 ET Champions Oncology, Inc. (CSBR) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 3.72%. The average open to low on the day of earnings was -8.77%. The average open ...

2025-07-15 18:41:05 ET Champions Oncology, Inc. (CSBR) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CSBR stock price following earnings has averaged ±3.66% , with a median of 2.63%....

Expanded offering delivers integrated radiopharmaceutical studies using clinically relevant isotopes and highly characterized PDX tumor models HACKENSACK, NJ / ACCESS Newswire / July 8, 2025 / Champions Oncology (NASDAQ:CSBR) a leading translational oncology research organization, today a...

2025-07-01 11:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-06-16 14:47:24 ET Summary Read the full article on Seeking Alpha For further details see: Champions Oncology: Biological IP Is The Real Asset - Not Preclinical Services

HACKENSACK, NJ / ACCESS Newswire / April 28, 2025 / Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in preclinical studies. This approval allows in-house work utilizing a variety of clinically relevant radio...

HACKENSACK, NJ / ACCESS Newswire / April 24, 2025 / Champions Oncology (NASDAQ:CSBR), a global leader in oncology R&D solutions, has announced a strategic collaboration with Turbine, the creators of the world's first interpretable cell simulation platform. This partnership is set to revolu...

2025-03-11 20:07:06 ET Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Conference Call March 11, 2025 04:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Maj Soueidan - GeoInvesting George Marema - Par...